Stay updated on Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded the term 'Primary peritoneal carcinoma' and included a new resource link to the Genetic and Rare Diseases Information Center. Page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; no substantive changes to study details are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section with Washington site details and updated the page revision to v3.3.3. Removed the Washington Locations entry and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check92 days agoChange DetectedPublications section updated to indicate entries are automatically filled from PubMed and may not all reference the study. Revision: v3.3.2.SummaryDifference0.1%

- Check100 days agoChange DetectedThe government funding notice at the top of the page was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.